International safety notice
VIRAL LOAD MONITORING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1)
Brazil / Anvisa · BRA · Nov 24, 2015
Key facts
| Title | VIRAL LOAD MONITORING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) |
|---|---|
| Regulator | Brazil / Anvisa |
| Country | BRA |
| Brand | ABBOTT REALTIME HIV-1 AMPLIFICATION REAGENT KIT, registration: 80146501493, Risk class: IV; |
| Manufacturer | DETENTOR DO REGISTRO ABBOTT LABORATÓRIOS DO BRASIL LTDA CNPJ 56998701000116 ENDEREÇO RUA MICHIGAN 735 CIDADE MONÇÕES SÃO PAULO FABRICANTE ABBOTT MOLECULAR INC ENDEREÇO DES PLAINES IL 60018 |
| Models | 462605, HIV-1, 80146501493 |
| Date | Nov 24, 2015 |
| Regulator page | anvisa.gov.br |
At a glance
- No Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
- 1–9 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1